Results 21 to 30 of about 72,644 (316)

Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma

open access: yesCase Reports in Nephrology, 2022
Malignant pleural mesothelioma is rarely associated with nephrotic syndrome. Cryoglobulinemia is found in various pathological statuses, such as hepatitis C virus infection but rarely in malignant neoplasms.
Kei Nagai   +3 more
doaj   +1 more source

Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature

open access: yesJournal of Thoracic Disease, 2021
The malignant pleural mesothelioma is a very aggressive tumor which is arising from mesothelial cells and is associated with asbestos exposure. It is a heterogeneous cancer that shows a complex pattern of molecular changes, including genetic, chromosomic,
S. Schumann, G. Kocher, F. Minervini
semanticscholar   +1 more source

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival

open access: yesMolecular Oncology, 2020
Development of precision medicine for malignant pleural mesothelioma (MPM) requires a deep knowledge of tumor heterogeneity. Histologic and molecular classifications and histo‐molecular gradients have been proposed to describe heterogeneity, but a deeper
Lisa Quetel   +20 more
semanticscholar   +1 more source

Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion

open access: yesThoracic Cancer, 2020
Malignant tumors are often associated with eosinophilic pleural effusion. Here, we encountered a case of interleukin‐5 (IL‐5)‐producing malignant pleural mesothelioma with eosinophilic pleural effusion. The patient was a 50‐year‐old male.
Eiji Takeuchi   +6 more
doaj   +1 more source

The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review

open access: yesCancers, 2021
Simple Summary Malignant pleural mesothelioma is a rare and aggressive tumour, associated with asbestos exposure. Current therapeutic approaches for malignant mesothelioma are mainly based on systemic chemotherapy with a median overall survival of less ...
Anne-Laure Désage   +3 more
semanticscholar   +1 more source

Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X. [PDF]

open access: yes, 2017
Malignant mesothelioma is a rare cancer that arises from the mesothelial cells that line the pleural cavity and less commonly from the peritoneal lining of the abdomen and pelvis.
Bastian, Boris C   +10 more
core   +2 more sources

Role of interleukin-6 (IL-6) in diagnosis of malignant pleural mesothelioma

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2015
Aim of the work: To evaluate the role of interleukin-6 (IL-6) in diagnosis of malignant pleural mesothelioma by detecting its level in the pleural fluid and serum of the patient with malignant pleural mesothelioma in comparison with other causes of ...
Rehab El Sayed   +4 more
doaj   +1 more source

Can malignant and inflammatory pleural effusions in dogs be distinguished using computed tomography [PDF]

open access: yes, 2017
Computed tomography (CT) is the primary imaging modality used to investigate human patients with suspected malignant or inflammatory pleural effusion, but there is a lack of information about the clinical use of this test in dogs.
Aquino   +35 more
core   +1 more source

Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future

open access: yesFrontiers in Oncology, 2020
Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer of the pleural surface associated with asbestos exposure. The median survival of MPM patients is a mere 8–14 months, and there are few biomarkers and no cure available.
F. Nicolini   +6 more
semanticscholar   +1 more source

New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials. [PDF]

open access: yes, 2015
Malignant pleural mesothelioma (MPM) is a rare tumor that is challenging to control. Despite some benefit from using the multimodality-approach (surgery, combination chemotherapy and radiation), survival remains poor. However, current research produced a
Cameron, Robert B   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy